1. Home
  2. VNDA vs TKNO Comparison

VNDA vs TKNO Comparison

Compare VNDA & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.26

Market Cap

361.4M

Sector

Health Care

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$5.37

Market Cap

308.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNDA
TKNO
Founded
2002
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.4M
308.3M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
VNDA
TKNO
Price
$6.26
$5.37
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$14.90
N/A
AVG Volume (30 Days)
905.2K
228.2K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.86
EPS
N/A
N/A
Revenue
$216,105,000.00
$40,520,000.00
Revenue This Year
$21.35
$8.27
Revenue Next Year
$37.40
$13.13
P/E Ratio
N/A
N/A
Revenue Growth
8.72
7.35
52 Week Low
$4.14
$1.91
52 Week High
$9.91
$6.68

Technical Indicators

Market Signals
Indicator
VNDA
TKNO
Relative Strength Index (RSI) 51.73 55.21
Support Level $5.97 $4.79
Resistance Level $6.73 $5.84
Average True Range (ATR) 0.21 0.43
MACD 0.07 -0.06
Stochastic Oscillator 54.72 43.93

Price Performance

Historical Comparison
VNDA
TKNO

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

Share on Social Networks: